Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux
Phase 4
Terminated
- Conditions
- Laryngopharyngeal Reflux
- Interventions
- Dietary Supplement: Sugar pill
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2012-08-24
- Lead Sponsor
- American Institute for Voice and Ear Research
- Target Recruit Count
- 18
- Registration Number
- NCT00369265
- Locations
- 🇺🇸
Henry Ford Hospital, Department of Otolaryngology, Detroit, Michigan, United States
🇺🇸American Institute for Voice and Ear Research, Philadelphia, Pennsylvania, United States
🇺🇸Cornell University, Van Lawrence Voice Center, Houston, Texas, United States
News
No news found